imfinzi-conc-for-soln-for-infusion-50-mg-ml

Imfinzi conc for soln for infusion 50 mg/mL (500 mg/10 mL)

Manufacturer: AstraZeneca

Distributor: Zuellig Pharma

Contents: durvalumab

MIMS Class: Cancer Immunotherapy

Form: Vial

Shape: Undefined

Exclusive offer for doctors

Sign up with email

Already a member? Sign in